TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study published in Nature Medicine found that levels of 16 blood molecules linked to brain aging and dementia risk rise across the menopause transition. In separate groups of older women, higher levels of the proteins were associated with poorer cognitive outcomes and a modestly greater Alzheimer’s dementia risk over 16 years; the findings do not show that menopause causes dementia.
Researchers from UC Santa Barbara, UC San Francisco and collaborating institutions have identified 16 blood molecules whose levels change across the menopause transition and are associated with markers of brain aging. The study, published in Nature Medicine, also found that higher levels of the proteins were linked to poorer cognitive outcomes in older women and a modestly greater risk of Alzheimer’s dementia in one large cohort, but it does not establish that menopause causes dementia.
The researchers used advanced proteomic methods to measure thousands of proteins in women at different stages of menopause. In the Healthy Aging Study, they identified changes in proteins related to inflammation and neuronal processes, as well as molecules associated with Alzheimer’s disease. The protein patterns were more closely related to menopause stage than to participants’ exact ages, suggesting that the transition may be associated with biological shifts beyond those linked to aging alone.
The team compared its findings with data from more than 2,800 women in the UK Biobank. That analysis also connected menopause with molecular signatures of accelerated aging across multiple organ systems. To examine later-life brain outcomes, the researchers then analyzed data from four independent cohorts totaling nearly 12,000 older women. Women with higher levels of the identified “risk” proteins tended to have poorer cognitive outcomes. In the largest cohort, the protein signature was associated with a modestly greater chance of developing Alzheimer’s dementia over the following 16 years.
These associations do not mean that the proteins themselves cause dementia, or that a person with higher levels will develop the disease. The researchers said the clinical meaning of individual Alzheimer’s-related protein differences detected in midlife remains uncertain. The study’s lead authors include Madeline Wood Alexander of Sunnybrook Research Institute and Rowan Saloner and Kaitlin Casaletto of UCSF, with collaborators from UCSB, Stanford University, the University of Toronto and other institutions.
Menopause as a Brain-Health Window
The findings offer researchers a possible way to study how a major midlife biological transition relates to brain health much later in life. If further work confirms that particular protein patterns are informative, blood-based measures could eventually help identify people who might benefit from closer monitoring or preventive research. That possibility is still a research goal, not a test clinicians can currently use based on this study.
The work also shifts attention from treating menopause only as a reproductive event. The team describes it as a whole-body transition that may coincide with changes in several biological systems. This matters to readers because cognitive changes and dementia risk are concerns for many people, while the study cautions against treating menopause itself as a diagnosis or a prediction of future Alzheimer’s disease. Most women do not develop Alzheimer’s, according to senior author Casaletto as reported in the source material.
Products Worth Considering
Fitbit Inspire 3 Health and Fitness Tracker Bundle
Fitbit Charge 6 Fitness Tracker – Obsidian/Black
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
As an affiliate, we earn on qualifying purchases.
How Researchers Traced Protein Changes
Menopause involves endocrine changes and can coincide with symptoms such as hot flashes, sleep disruption and what is often described as brain fog. The study examined molecular patterns in blood rather than treating those symptoms as evidence of dementia. Its focus was whether proteins changing across menopause might also be associated with cognitive health later in life.
The researchers combined analyses of women at different menopause stages with external data and older-adult cohorts. This breadth supports the reported associations, but the analyses do not substitute for following the same women over time to see how hormone levels, protein changes, symptoms and brain health develop together. The research was supported in part by the Ann S. Bowers Women’s Brain Health Initiative, Wellcome Leap, the National Institutes of Health and the Noyce Trust. The paper is titled “Blood proteomics of menopause map to brain aging and dementia risk.”
““Menopause is not an isolated reproductive event. It is a whole-body biological transition.””
— Emily Jacobs, professor of psychological and brain sciences at UC Santa Barbara
Causation and Individual Risk Remain Unknown
The study does not show that menopause causes Alzheimer’s disease, that the identified proteins cause dementia, or that the findings can predict an individual woman’s future health. The reported association with Alzheimer’s dementia was modest and came from the largest of the older-women cohorts. The clinical significance of individual protein changes measured in midlife also remains uncertain.
The source report does not provide enough detail to assess the size of every effect, the precise thresholds for protein levels, or how well the pattern would perform as a clinical screening test. It is also not yet clear how changes in hormones, proteins, symptoms and cognition relate to one another within the same people over time. The researchers say longitudinal research is needed to address those questions.
Longitudinal Menopause Study Planned
UCSB researchers and collaborators are launching the Longitudinal Menopause Project to follow women across the menopause transition and track biological and brain-health measures over time. The team is actively recruiting researchers, according to the report. Following the same participants could help establish how changes unfold and whether menopause-related protein patterns have value for identifying risk or resilience.
The researchers have described development of a blood test as a longer-term goal, likening its proposed role to how cholesterol testing helps assess heart disease risk. No such dementia-risk test is established by the current findings. Further studies will need to validate the protein signature, clarify its clinical meaning and determine whether interventions during midlife can improve later brain-health outcomes.
Key Questions
Does the study show that menopause causes Alzheimer’s disease?
No. The study found associations between menopause-related protein patterns and later cognitive outcomes, but it does not establish that menopause or the proteins cause Alzheimer’s disease.
What did researchers identify?
They reported changes in the levels of 16 molecules linked to brain aging and dementia risk across the menopause transition. The proteins were involved in processes including inflammation and neuronal function.
Does this mean a woman with these protein changes will develop dementia?
No. The study does not provide an individual prediction. Higher levels were associated with poorer outcomes at a group level, and the clinical meaning of the midlife protein changes remains uncertain.
Is there a blood test based on these findings?
No validated clinical test was reported. The researchers described a blood test as a future goal that would require additional research and validation.
What research comes next?
The team is launching the Longitudinal Menopause Project to study how hormones, proteins, symptoms and brain health change together over time. Such follow-up work may clarify the associations reported in this study.
Source: news-medical.net
